Authoring a Clinical Study Protocol – II

Authoring a Clinical Study Protocol – II

Dr. Nimita Limaye returns to continue answering our guest audience questions in regards to authoring a clinical study protocol! This week, she explains the importance of protocol synopsis and ensuring the completeness of the protocol, as well as defines crowdsourcing...
The Need for Culturally Sensitive Interpreters During COVID-19

The Need for Culturally Sensitive Interpreters During COVID-19

Medical interpreters play several important roles in a clinical setting where multiple languages are spoken. Beyond real-time translation, medical interpreters are culturally aware and can communicate important concepts, as well as extract crucial information...
WHO Prequalifies Rituximab Biosimilar

WHO Prequalifies Rituximab Biosimilar

The World Health Organization (WHO) has prequalified a biosimilar of version of rituximab, which is used to treat certain cancers and autoimmune diseases, created by Celltrion.  This drug therapy is the second to achieve prequalification status under the...